
Venture capital · Early stage
Agent Capital
Healthcare venture capital firm making direct equity investments in novel therapeutics companies, from preclinical through commercial stages, in areas of high unmet patient need.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Agent Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Agent Capital joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, Agent Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Agent Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Agent Capital
Events where Agent Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Agent Capital is based in Waltham, United States.
3 fund vehicles are on public registers (SEC adviser filings), including AGENT CAPITAL FUND II LP, AGENT CAPITAL FUND III LP and AGENT CAPITAL FUND I LP.
Stages: Seed. Sectors: Biotech. From the firm’s own website.
Backs novel, differentiated therapeutics addressing high unmet medical need, with a primary focus on rare diseases, oncology, neurology and immunology. Partners with scientists and entrepreneurs, leads or co-leads rounds, and guides companies to milestones and exits using its pharma executive network. From the firm’s own website.
Agent Capital lists 36 portfolio companies on its website, including Affini-T, Alveus Therapeutics, AshiBio, Carbon Biosciences and Carisma Therapeutics.
Firms whose websites list some of the same companies include RA Capital, Catalio Capital Management and Foresite Capital.
Know before Agent Capital’s next round is announced.
PRO tracks Agent Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.